We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Acetazolamide for injection, USP 500mg vial (XGen)
Section 19A approved medicine
Acetazolamide for injection, USP 500mg vial (XGen)
Section 19A approval holder
Phebra Pty Ltd ABN 99 059 357 890
Phone
1800 720 020
Approved until
Status
Current
Medicines in short supply/unavailable
GLAUMOX acetazolamide (as sodium) 500 mg powder for injection vial - ARTG 142075
Indication(s)
For adjunctive treatment of: oedema due to congestive heart failure; drug-induced oedema; entrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (openangle glaucoma, secondary glaucoma and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.
Images
